Tebufelone is a potent in vitro inhibitor of CO , a novel non-steroidal anti-inflammatory drug (NSAID) belonging to the di-tert-butylphenol (DTBP) class that has shown potent anti-inflammatory, analgesic and anti-reticulitis properties in various animal models. Tebufelone potently inhibits the formation of prostaglandins (PGE2) and blocks the formation of lipoxygenase pathway products [leukotriene (LTB4)] in rat macrophages (IC50 = 20 microM) and human whole blood (IC50 = 22 microM) in vitro. = 20 microM) and human whole blood (IC50 = 22 microM) from the formation of lipoxygenase pathway products [leukotriene (LTB4)] in vitro.
Molecular Weight:
300.44
Purity:
99.61%
CAS Number:
[112018-00-5]
Formula:
C20H28O2
Target:
Lipoxygenase|||LTR|||Prostaglandin Receptor|||COX
T68155
* VAT and and shipping costs not included. Errors and price changes excepted
